The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index.
Identification of a Mammalian Angiopoietin-Related Protein Expressed Specifically in Liver
Abstract
Based on searches of EST databases for signal sequences and amphipathic helices, we have identified and cloned an angiopoietin-like gene, ANGPTL3. Multiple tissue Northern blots show that ANGPTL3 is expressed principally in the liver. ANGPTL3 is expressed early during liver development, and expression is maintained in adult liver. Human ANGPTL3 is a 460-amino-acid polypeptide with the characteristic structure of angiopoietins: a signal peptide, an extended helical domain predicted to form dimeric or trimeric coiled-coils, a short linker peptide, and a globular fibrinogen homology domain (FHD). Murine ANGPTL3 is a 455-acid polypeptide encoded by seven exons on mouse chromosome 4, spanning about 11 kb of DNA. ANGPTL3 contains the four conserved cysteines implicated in the intramolecular disulfide bonds within the FHD, but it does not contain two other cysteines that are found within the FHD of angiopoietins 1, 2, and 4. ANGPTL3 also does not contain the characteristic calcium binding motif found in the other angiopoietins. By radiation hybrid mapping and the use of surrounding genes, human ANGPTL3 maps to the 1p31 region.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They found that this protein, which they named ANGPTL3, was expressed almost exclusively in the liver in both mice and humans (103).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [103]
In the citing paper
“found a 460-amino acid protein with the conserved secondary structure of the ANGPTL family (a signal peptide followed by an N-terminal coil-coil domain with a linker leading to a C-terminal fibrinogen-like domain).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [103]
In the citing paper
“ANGPTL3 is expressed in and secreted from the liver and circulates in the bloodstream (15, 40, 72, 103).”
From Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8 (2021) · cites this paper as [103]
In the citing paper
“ANGPTL3 is exclusively expressed and secreted by the liver and has emerged as an important regulator of plasma triglyceride levels due to its inhibition of LPL in oxidative tissues [34] (Figure 3).”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [34]
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
A new method for predicting signal sequence cleavage sites
von HEIJNE, G. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.11.4683 · Cited by 4,473
Predicting coiled coils from protein sequences.
Lupas, A., Van Dyke, M., & Stock, J. (1991) · Science · doi:10.1126/science.252.5009.1162 · Cited by 3,953
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S. H., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,872
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Signaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,185
MultiCoil: A program for predicting two‐and three‐stranded coiled coils
Wolf, E., Kim, P. S., & Berger, B. (1997) · Protein Science · doi:10.1002/pro.5560060606 · Cited by 720
Predicting coiled coils by use of pairwise residue correlations.
Berger, B., Wilson, D. B., Wolf, E., Tonchev, T., Milla, M. E., & Kim, P. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8259 · Cited by 622
Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
Valenzuela, D. M., Griffiths, J. A., Rojas, J., Aldrich, T. H., Jones, P. F., Zhou, H., McClain, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1904 · Cited by 477
Cited by
Sorted by citations
Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427
Romeo, S., Yin, W., Kozlitina, J., Pennacchio, L. A., Boerwinkle, E., Hobbs, H. H., & Cohen, J. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci37118 · Cited by 58
Angptl3 regulates lipid metabolism in mice
Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., & Furukawa, H. (2002) · Nature Genetics · doi:10.1038/ng814 · Cited by 379
Yoshida, K., Shimizugawa, T., Ono, M., & Furukawa, H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.c200010-jlr200 · Cited by 317
Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells
Zhang, C. C., Kaba, M., Ge, G., Xie, K. T., Tong, W., Hug, C., & Lodish, H. F. (2006) · Nature Medicine · doi:10.1038/nm1342 · Cited by 372
Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., Shimizugawa, T., Ando, Y., Koishi, R., Kohama, T., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000252827.51626.89 · Cited by 297
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 288
Genetic determinants of plasma triglycerides
Johansen, C. T., Kathiresan, S., & Hegele, R. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r009720 · Cited by 264
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252
Camenisch, G., Pisabarro, M. T., Sherman, D. A., Kowalski, J., Nagel, M., Hass, P., Xie, M.-H., Gurney, A. L., Bodary, S. C., Liang, X. H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109768200 · Cited by 253
Microrna-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia
Vickers, K. C., Shoucri, B. M., Levin, M. G., Wu, H., Pearson, D. S., Osei-Hwedieh, D. O., Collins, F. S., Remaley, A. T., & Sethupathy, P. (2012) · Hepatology · doi:10.1002/hep.25846 · Cited by 235
Angiopoietin-like 3 in lipoprotein metabolism
Kersten, S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.119 · Cited by 220
Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3)
Ono, M., Shimizugawa, T., Shimamura, M., Yoshida, K., Noji-Sakikawa, C., Ando, Y., Koishi, R., & Furukawa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302861200 · Cited by 195
Qu, A., Taylor, M. J., Xue, X., Matsubara, T., METZGER, D., Chambon, P., Gonzalez, F. J., & Shah, Y. M. (2011) · Hepatology · doi:10.1002/hep.24400 · Cited by 181
ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase
Chi, X., Britt, E. C., Shows, H. W., Hjelmaas, A. J., Shetty, S. K., Cushing, E. M., Li, W., Dou, A., Zhang, R., & Davies, B. S. J. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.014 · Cited by 174
A review on pro- and anti-angiogenic factors as targets of clinical intervention
Bouïs, D., Kusumanto, Y. H., MEIJER, C., MULDER, N., & Hospers, G. A. P. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.10.006 · Cited by 166
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8
Sylvers-Davie, K. L., & Davies, B. S. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00195.2021 · Cited by 154
Angiopoietin-like Protein 3 Mediates Hypertriglyceridemia Induced by the Liver X Receptor
Inaba, T., Matsuda, M., Shimamura, M., Takei, N., Terasaka, N., Ando, Y., Yasumo, H., Koishi, R., Makishima, M., & Shimomura, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213202200 · Cited by 138
Hepatic ANGPTL3 regulates adipose tissue energy homeostasis
Wang, Y., McNutt, M. C., Banfi, S., Levin, M. G., Holland, W. L., Gusarova, V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515374112 · Cited by 134
Eising, E., Mirza‐Schreiber, N., de Zeeuw, E. L., Wang, C. A., Truong, D. T., Allegrini, A. G., Shapland, C. Y., Zhu, G., Wigg, K. G., Gerritse, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202764119 · Cited by 150
The role of ANGPTL3 in controlling lipoprotein metabolism
Tikka, A., & Jauhiainen, M. (2016) · Endocrine · doi:10.1007/s12020-015-0838-9 · Cited by 134
Regulation of the angiopoietin-like protein 3 gene by LXR
Kaplan, R., Zhang, T., Hernandez, M., Gan, F. X., Wright, S. D., Waters, M. G., & Cai, T.-Q. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200367-jlr200 · Cited by 106
Regulation of lipid metabolism via angiopoietin-like proteins
Kersten, S. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051059 · Cited by 123
Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes
Shimamura, M., Matsuda, M., Kobayashi, S., Ando, Y., Ono, M., Koishi, R., Furukawa, H., Makishima, M., & Shimomura, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03058-9 · Cited by 111
A large-scale analysis of mRNAs expressed by primary mesenchyme cells of the sea urchin embryo
Zhu, X., Mahairas, G. G., Illies, M. R., Cameron, R. A., Davidson, E. H., & Ettensohn, C. A. (2001) · Development · doi:10.1242/dev.128.13.2615 · Cited by 112
Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample
Robciuc, M. R., Tahvanainen, E., Jauhiainen, M., & Ehnholm, C. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002618 · Cited by 107
Angptl3-null Mice Show Low Plasma Lipid Concentrations by Enhanced Lipoprotein Lipase Activity
FUJIMOTO, K., KOISHI, R., SHIMIZUGAWA, T., & ANDO, Y. (2006) · Experimental Animals · doi:10.1538/expanim.55.27 · Cited by 104
Ando, Y., Shimizugawa, T., Takeshita, S., Ono, M., Shimamura, M., Koishi, R., & Furukawa, H. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300031-jlr200 · Cited by 100
The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress
Włodarski, A., Strycharz, J., Wróblewski, A. M., Kasznicki, J., Drzewoski, J., & Śliwińska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186902 · Cited by 99
Ruscica, M., Zimetti, F., Adorni, M. P., Sirtori, C. R., Lupo, M. G., & Ferri, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104653 · Cited by 85
ANGPTL8 has both endocrine and autocrine effects on substrate utilization
Oldoni, F., Cheng, H., Banfi, S., Gusarova, V., Cohen, J. C., & Hobbs, H. H. (2020) · JCI Insight · doi:10.1172/jci.insight.138777 · Cited by 73
Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
Chen, P., Gao, W.-Y., Liou, J.-W., Lin, C.-Y., Wu, M., & Yen, J.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147310 · Cited by 80
Modulation of plasma TG lipolysis by Angiopoietin-like proteins and GPIHBP1
Lichtenstein, L., & Kersten, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.015 · Cited by 78
Shimamura, M., Matsuda, M., Ando, Y., Koishi, R., Yasumo, H., Furukawa, H., & Shimomura, I. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.024 · Cited by 67
The Lipoprotein Lipase Inhibitor ANGPTL3 Is Negatively Regulated by Thyroid Hormone
Fugier, C., Tousaint, J.-J., Prieur, X., Plateroti, M., Samarut, J., & Delerive, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512554200 · Cited by 60
Gerwin, N., Scotti, C., Halleux, C. M., Fornaro, M., Elliott, J., Zhang, Y., Johnson, K., Shi, J. Y., Walter, S., Li, Y., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02059-9 · Cited by 73
Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation
Li, J., Li, L., Guo, D., Li, S., Zeng, Y., Liu, C., Fu, R., Huang, M., & Xie, W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.029 · Cited by 67
The Mulberry, Morus alba (L.): The Medicinal Herbal Source for Human Health
Kadam, R. A., Dhumal, N. D., & Khyade, V. B. (2019) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2019.804.341 · Cited by 65
Morelli, M. B., Chavez, C., & Santulli, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1707806 · Cited by 64
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
Lupo, M. G., & Ferri, N. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5030039 · Cited by 64
Furin Is the Primary in Vivo Convertase of Angiopoietin-like 3 and Endothelial Lipase in Hepatocytes
Essalmani, R., Susan-Resiga, D., Chamberland, A., Asselin, M.-C., Canuel, M., Constam, D., Creemers, J. W., Day, R., Gauthier, D., Prat, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.501304 · Cited by 54
Mucosal gatekeepers: Selecting HIV viruses for early infection
Bomsel, M., & David, V. (2002) · Nature Medicine · doi:10.1038/nm0202-114 · Cited by 61
Comparative integromics on Angiopoietin family members
Katoh, Y., & Katoh, M. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.6.1145 · Cited by 61
Dutton, S., & Trayhurn, P. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507882961 · Cited by 59
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
Luo, F., Das, A., Khetarpal, S. A., Fang, Z., Zelniker, T. A., Rosenson, R. S., & Qamar, A. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2023.01.008 · Cited by 58
Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes
Christopoulou, E. C., Elisaf, M., & Filippatos, T. D. (2019) · Disease Markers · doi:10.1155/2019/6578327 · Cited by 56
Lin, Y., Rao, J., Zha, X., & Xu, H. M. (2013) · BioMed Research International · doi:10.1155/2013/135608 · Cited by 57
Isolation and expression analysis of three zebrafish angiopoietin genes
Pham, V. N., Roman, B. L., & Weinstein, B. M. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1157 · Cited by 54
Complexity of microRNA function and the role of isomiRs in lipid homeostasis
Vickers, K. C., Sethupathy, P., Baran‐Gale, J., & Remaley, A. T. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r034801 · Cited by 52
Oteng, A.-B., Ruppert, P. M., Boutens, L., Dijk, W., van Dierendonck, X. M. H., Olivecrona, G., Stienstra, R., & Kersten, S. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m094128 · Cited by 46
The Angiopoietin-like Factor Cornea-derived Transcript 6 Is a Putative Morphogen for Human Cornea
Peek, R., Kammerer, R. A., Frank, S., Otte‐Höller, I., & Westphal, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105746200 · Cited by 49
ANGPTL3 as a Drug Target in Hyperlipidemia and Atherosclerosis
Mohamed, F., Mansfield, B. S., & Raal, F. J. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01071-1 · Cited by 48
Jeong, W., Lim, W., Ahn, S. E., Lim, C.-H., Lee, J.-Y., Bae, S.-M., Kim, J., Bazer, F. W., & Song, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076784 · Cited by 49
New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases
Su, X., & Peng, D. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0659-y · Cited by 45
A novel role of angiopoietin-like-3 associated with podocyte injury
Liu, J., Gao, X., Zhai, Y., Shen, Q., Sun, L., Feng, C., Rao, J., Liu, H., Zha, X., Guo, M., et al. (2015) · Pediatric Research · doi:10.1038/pr.2015.38 · Cited by 43
Korstanje, R., Eriksson, P. O., Samnegård, A., Olsson, P. G., Forsman‐Semb, K., Sen, Ś., Churchill, G. A., Rollins, J. A., Harris, S. J., Hamsten, A., et al. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.006 · Cited by 43
Targeting the vasculature in cardiometabolic disease
Boutagy, N. E., Singh, A. K., & Sessa, W. C. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148556 · Cited by 45
ANGPTL3: a novel biomarker and promising therapeutic target
Jiang, S., Qiu, G.-H., Zhu, N., Hu, Z., Liao, D., & Li, Q. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1566342 · Cited by 41
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity
Wen, Y., Chen, Y., & Konrad, R. J. (2022) · Advanced Biology · doi:10.1002/adbi.202200093 · Cited by 43
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Tikka, A., Soronen, J., Laurila, P., Metso, J., Ehnholm, C., & Jauhiainen, M. (2014) · Bioscience Reports · doi:10.1042/bsr20140115 · Cited by 39
Dai, R., Lin, Y., Liu, H., Rao, J., Zhai, Y., Zha, X., Fang, X., & Xu, H. M. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0034-4 · Cited by 39
Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia
Nurmohamed, N. S., Dallinga‐Thie, G. M., & Stroes, E. S. G. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1768848 · Cited by 42
Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Tomlinson, B., Wu, Q., Zhong, Y.-M., & Li, Y. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.1.2 · Cited by 39
Identification of a novel human angiopoietin-like gene expressed mainly in heart
Zeng, L., Dai, J., Ying, K., Zhao, E., Jin, W., Ye, Y., Dai, J., Xu, J., Xie, Y., & Mao, Y. (2003) · Journal of Human Genetics · doi:10.1007/s100380300025 · Cited by 36
Thorin, É., Labbé, P., Lambert, M., Mury, P., Dagher, O., Miquel, G., & Thorin‐Trescases, N. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.06.002 · Cited by 37
Gao, X., Xu, H. M., Liu, H., Rao, J., Li, Y., & Zha, X. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.027 · Cited by 35
Legry, V., Bokor, S., Cottel, D., Béghin, L., Catasta, G., Nagy, E., González‐Gross, M., Spinneker, A., Stehle, P., Molnár, D., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0769 · Cited by 35
Zuo, Y., Zhang, C., Zhou, Y., Li, H., Xiao, W., Herzog, R. W., Xu, J., Zhang, J., Chen, Y. E., & Han, R. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01036-0 · Cited by 33
Fasting-induced adipose factor/angiopoietin–like protein 4: a potential target for dyslipidemia?
Zandbergen, F., van Dijk, S., Müller, M., & Kersten, S. (2006) · Future Lipidology · doi:10.2217/17460875.1.2.227 · Cited by 29
Yang, J. X., Song, Q., Niu, S., Chen, H., Petersen, R. B., Zhang, Y., & Huang, K. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30534 · Cited by 33
Zhao, D., Yang, L., Wang, X., Yuan, S., Yu, C., Wang, Z., Lang, J., & Feng, Y. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0450-1 · Cited by 28
Chen, P., Chao, T.-Y., Hsu, H., Wang, C., Lin, C.-Y., Gao, W.-Y., Wu, M., & Yen, J.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189853 · Cited by 25
Liu, X., Zhang, Y., Han, B., Li, L., Li, Y., Ma, Y., Kang, S., Li, Q., Kong, L., Huang, K., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.181553 · Cited by 25
Cloning, chromosome mapping and expression characteristics of porcine ANGPTL3 and -4
Feng, S., Chen, X., Xia, T., Gan, L., Qiu, H., Dai, M. H., Zhou, L., Peng, Y., & Yang, Z. Q. (2006) · Cytogenetic and Genome Research · doi:10.1159/000091927 · Cited by 24
ANGPLT3: A novel modulator of lipid metabolism
Hassan, M. S. (2017) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2017.6 · Cited by 24
Paeoniflorin regulates GALNT2-ANGPTL3-LPL pathway to attenuate dyslipidemia in mice
Xiao, H., Liang, L., Luo, Z.-F., & Sun, Z. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.006 · Cited by 24
Angioarrestin: A unique angiopoietin-related protein with anti-angiogenic properties
Dhanabal, M., Jeffers, M., LaRochelle, W. J., & Lichenstein, H. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.134 · Cited by 24
New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
Kim, J. Y., & Kim, N. H. (2023) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2023.12.1.23 · Cited by 23
Kwon, M.-H., Ryu, J., Kim, W. J., Jin, H., Song, K., Kwon, K.-D., Batbold, D., Yin, G. N., Koh, G. Y., & Suh, J. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12278 · Cited by 23
Kim, H.-S., Deng, L., Xiong, X., Hunter, W. D., Long, M. C., & Pirrung, M. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070437i · Cited by 23
Li, Y., Sun, L., Xu, H. M., Fang, Z., Yao, W., Guo, W., Rao, J., & Zha, X. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00421.x · Cited by 23
Angiopoietin-like 8 (Angptl8) controls adipocyte lipolysis and phospholipid composition
Mysore, R., Liebisch, G., Zhou, Y., Olkkonen, V. M., & Haridas, P. A. N. (2017) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2017.05.002 · Cited by 21
Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis
Lu, X. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190621120523 · Cited by 22
Evinacumab: Mechanism of action, clinical, and translational science
Dingman, R., Bihorel, S., Gusarova, V., Mendell, J., & Pordy, R. (2024) · Clinical and Translational Science · doi:10.1111/cts.13836 · Cited by 23
Dutta, R. K., Lee, J. N., Maharjan, Y., Park, C., Choe, S., Ho, Y., & Park, R. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00710-5 · Cited by 21
Angiopoietin-like 3: An important protein in regulating lipoprotein levels
Burks, K. H., Basu, D., Goldberg, I. J., & Stitziel, N. O. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101688 · Cited by 21
Efficacy and Safety of Evinacumab for the Treatment of Hypercholesterolemia: A Meta-Analysis
Jin, M., Meng, F., Yang, W., Liang, L., Wang, H., & Zhenyan, F. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001073 · Cited by 22
Targeting PCSK9 and Beyond for the Management of Low-Density Lipoprotein Cholesterol
Mohamed, F., Mansfield, B. S., & Raal, F. J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12155082 · Cited by 20
Novel Experimental Agents for the Treatment of Hypercholesterolemia
Pećin, I., & Reiner, Ž. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s267376 · Cited by 19
Hess, A. L., Carayol, J., Blædel, T., Hager, J., Cara, A. D., Astrup, A. V., Saris, W. H. M., Larsen, L. H., & Valsesia, A. (2018) · Genes & Nutrition · doi:10.1186/s12263-018-0597-3 · Cited by 18
Ruhanen, H., Haridas, P. A. N., Jauhiainen, M., & Olkkonen, V. M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158791 · Cited by 18
Modder, M., Panhuis, W. I. H., Li, M., Afkir, S., Dorn, A. L., Pronk, A. C. M., Streefland, T. C. M., Lalai, R. A., Pierrou, S. E., Nilsson, S. K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae195 · Cited by 17
Macromolecular Interactions of Lipoprotein Lipase (LPL)
Wheless, A., Gunn, K. H., & Neher, S. B. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-58843-3_8 · Cited by 19
Role of the angiopoietin-like protein family in the progression of NAFLD
Su, X., Xu, Q., Li, Z., Ren, Y., Jiao, Q., Wang, L., & Wang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27739 · Cited by 18
Chen, N., Ma, Y., Yang, T., Lin, F., Fu, W., Xu, Y., Li, F., Li, J. Y., & Gao, S. (2015) · animal · doi:10.1017/s1751731115000658 · Cited by 16
How ANGPTL3 Inhibition Will Help Our Clinical Practice?
Bini, S., Tramontano, D., Minicocci, I., Costanzo, A. D., Tambaro, F., D’Erasmo, L., & Arca, M. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01076-w · Cited by 15
Targeting angiopoietin‐like 3 in atherosclerosis: From bench to bedside
Ling, P., Zheng, X., Luo, S., Ge, J., Xu, S., & Weng, J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14450 · Cited by 15
Levy, E. H., Beaulieu, J., & Spahis, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.629222 · Cited by 16
Lin, C.-Y., Chen, P., Hsu, H., Gao, W.-Y., Wu, M., & Yen, J.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012485 · Cited by 14
Metadata
- Authors
- Conklin, D., Gilbertson, D., Taft, D. W., Maurer, M. F., Whitmore, T. E., Smith, D. L., Walker, K. M., Chen, L. H., Wattler, S., Nehls, M., & Lewis, K. B.
- Corresponding author
- Conklin, Darrell
- Venue
- Genomics
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 62
- Issue
- 3
- Pages
- 477-482
- ISSN
- 0888-7543 (ISSN-L)
- OpenAlex
- W2033200911
- Cited by
- 169
- References
- 24
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 13 · 2022: 12 · 2021: 14 · 2020: 11 · 2019: 8 · 2018: 5 · 2017: 5 · 2016: 2 · 2015: 8 · 2014: 3 · 2013: 7 · 2012: 3
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Genomics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- ANGPTL3, angiopoietin-like proteins, liver-specific gene expression, angiopoietins, coiled-coil domain, signal peptide, gene cloning, mouse chromosome 4, radiation hybrid mapping, liver development, cysteine disulfide bonds
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 3, Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Chromosomes, Human, Pair 1, Glycosylation, Growth Substances, Humans, Liver, Membrane Glycoproteins, Molecular Sequence Data, Organ Specificity, Proteins, RNA, Messenger, Blotting, Northern, Sequence Homology, Amino Acid, Sequence Analysis, DNA, Physical Chromosome Mapping, Amino Acid Motifs, Intercellular Signaling Peptides and Proteins, Angiopoietins, Angiopoietin-1, Angiopoietin-2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review